Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 1, 2019

Study Completion Date

January 1, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

Coroflex® ISAR Drug-eluting stent

Coroflex® ISAR Drug-eluting stent and an Ultimaster® Drug-eluting stent in the second lesion.

DEVICE

Ultimaster® Drug-eluting stent

Ultimaster® Drug-eluting stent and a Coroflex® ISAR Drug-eluting stent in the second lesion.

Trial Locations (3)

24008

Hospital de León, León

08035

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

B.Braun Surgical SA

INDUSTRY

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER